Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

France: A Great Place For Investing

The economy of France is diversified across all sectors. The country's government has partially or fully privatized many large companies which include Air France, France Telecom, Renault and Thales. I am sharing about Sanofi S.A. which is also one of the Les actions Francaises à dividende. Investors should focus on it.

Sanofi SA (ADR)

Company Overview

It is formerly known as Sanofi-Aventis which is a France-based global and diversified healthcare company. It discovers, develops and distributes therapeutic solutions focused on patients' needs. The company has focus on the field of healthcare with six growth platforms which include solution diabetes, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. The company works to prevent and treat the disease that they know of today, as well as those they may face tomorrow.

The company is enthusiastic to advancing healthcare around the world having more than 100,000 dedicated exports in more than 100 countries. Its portfolio includes drugs prescription, vaccines, generics and consumer healthcare products. The company's activities are domestically and abroad, including other European countries, North and Latin Americas, Asia, Arica and Middle East.

History

In 1999 the Sanofi-Synthelabo was formed and Sanofi which was a former subsidiary of Total merged with Synthelabo. This merged company was based in Paris, France. The Aventis was created in 1999 at that time French company Rhone-Poulenc S.A merged with the German corporation Hoechst Marion Roussel. It itself was formed from the 1995 merger of Hoechst AG with Roussel Uclaf and Marion Merrell Dow.

The Sanofi-Avnetis was made in 2004. In the year the Sanofi-Synthelabo acquired Aventis. In 2004, Sanofi Synthelabo formed a hostile takeover bid worth $47.8 billion for Aventis. At the beginning the Aventis rejected the bid for the reason that it felt the bid was offering inferior value based on the company's share value.

The government of France desiring what they called a local solution, put heavy pressure on Sanofi-Synthelabo to raise its bid for Aventis after that it became known that Novartis a Swiss Pharmaceutical company, which was in the running.

Sanofi Vision

The company has established a North American Corporate Social Responsibility function. This will help further integrated this approach into their US and Canadian businesses. The company's Goal is to become a leader in Corporate Social Responsibility. The reason is they don't want to sell only healthcare products but also want to promote a healthy way of life and prevent healthcare issues. They are committed to their economic, social and environmental obligations support this business paradigm shift.

How dividends paid and taxed in Sanofi

The ADR dividends are paid in U.S dollars and usually they are taxable as well as Dividends on U.S. shares. Additionally the Republic of France Sanofi's home country, may withhold taxes. It depends on individual circumstances, foreign taxes withheld might be applied as a credit against U.S. taxes, or tax reclaim opportunities may be offered. If you are in doubt, consult your tax advisor.

Dividend History

The Company pays the dividends on an annual basis. Its current open price is 53.00, previous close 52.71. The company has a market capitalization of 139.87 Billion, EPS is 2.07, P/E ratio is 25.59 and the dividend yield is 3.39% at the annual dividend payout of 1.79.